ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Jun 21, 2016
Insider Transaction Report
Form 4
Titus Gary
Director
Transactions
- Award
Stock Option (right to buy)
2016-06-17+156,750→ 156,750 totalExercise: $0.24Exp: 2026-06-16→ Common Stock (156,750 underlying)
Footnotes (1)
- [F1]The option vests in equal quarterly installments for one year following June 17, 2016.